Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia

Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis

(2013) Masaomi Iyo et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis

(2011) S. Tadokoro et al.   SCHIZOPHRENIA BULLETIN

Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder

(2011) Takaharu Azekawa et al.   Neuropsychiatric Disease and Treatment

Predictors of Early Worsening after Switch to Aripiprazole

(2010) Chi-Un Pae et al.   CLINICAL DRUG INVESTIGATION

A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis

(2010) Paul Fallon et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors

(2009) Yoshihiro Tadori et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study

(2009) Chi-Un Pae et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder

(2009) Chang Yoon Kim et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Predictors of Clinical Worsening After a Switch to Aripiprazole in Patients With Schizophrenia

(2009) Hiroyoshi Takeuchi et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Supersensitivity psychosis and aripiprazole tapering

(2009) Chi-Un Pae   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Aripiprazole in combination with other antipsychotic drugs may worsen psychosis

(2008) J. Adan-Manes et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Partial compliance in schizophrenia and the impact on patient outcomes

(2008) Pierre-Michel Llorca   PSYCHIATRY RESEARCH

Atypical Antipsychotics: CATIE Study, Drug-Induced Movement Disorder and Resulting Iatrogenic Psychiatric-Like Symptoms, Supersensitivity Rebound Psychosis and Withdrawal Discontinuation Syndromes

(2008) Guy Chouinard et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS